Examination of the blood biomarker in examination testees, breast cancer patients and thyroid cancer patients

Examination of the blood biomarker in examination testees, breast cancer patients and thyroid cancer patients - Examination of the blood biomarker in examination testees, breast cancer patients and thyroid cancer patients

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014114

Enrollment

800

Registered

2014-05-30

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Thyroid cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Examinees Patients with breast cancer Patients with thyroid cancer

Exclusion criteria

Exclusion criteria: Creatinine abnormally high patient Patients who had cancer in the past, or have cancer at the present

Design outcomes

Primary

Measure	Time frame
The concentration of serum TFF of breast cancer and thyroid cancer patients. The concentration of serum TFF ofexaminees.	—

Countries

Japan

Contacts

Public ContactYuko Ishibashi

Graduate School of Medicine, The University of Tokyo Department of Metabolism Nutrition Endocrine Surgery

oyuko-t@umin.ac.jp03-3815-5411(ext.35144)

Outcome results